trial · primary record
Surovatamig
Rheumatoid Arthritis
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 48 |
| Primary completion | 2028-06-27 |
| Primary endpoint | Safety evaluation of surovatamig: Number of participants with treatment-emergent adverse events (TEAEs), serious adverse events (SAEs), adverse events of special interest (AESIs) |
| Registry ID | NCT07201558 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:38:27.026Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07201558
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Surovatamig · compound